The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8624514 8747386 I 8624514-3 20120820 20120827 EXP US-JNJFOC-20120810213 JANSSEN PHARMACEUTICALS, INC. YR Y 20120827 PH UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8624514 1020674018 SS XARELTO 1 ORAL UNKNOWN
8624514 1020674019 PS XARELTO 1 ORAL UNKNOWN 022406

Indications of drugs used

Event ID DRUG SEQ INDI PT
8624514 1020674018 THROMBOSIS PROPHYLAXIS
8624514 1020674019 KNEE ARTHROPLASTY

Outcome of event

Event ID OUTC COD
8624514 OT

Reactions reported

Event ID PT
8624514 PULMONARY EMBOLISM

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
8624514 1020674018 20120101
8624514 1020674019 20120101